Researchers have been studying multiple sclerosis (MS) in hopes of identifying subgroups of the disease to improve treatment outcomes. A new study from Germany identified three MS subtypes based on immune markers in patients’ blood, each with different disease progression. The study confirmed existing findings and also discovered new immunological activation patterns unique to each subgroup. These subgroups responded differently to treatments, providing insights for drug development and personalized treatment plans. While more research is needed to validate these findings, the study’s data is being used to develop tests and potentially transform MS patient care in the future.
Source link
Multiple sclerosis has subtypes with different best treatments: study
